E-602
N/A
Report date: 2025/10/29 17:47:32
First In Class
Base Information
Drug NameE-602
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[17]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesPalleon Pharmaceuticals Inc
China Registration ClassN/A
Develop Information
Active CompaniesPalleon Pharmaceuticals IncShanghai Henlius Biotech IncShanghai Henlius Biopharmaceuticals Co Ltd
Inactive CompaniesN/A
Active Indications +[17]
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A